Edgewise Therapeutics, Inc. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Edgewise Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
Edgewise Therapeutics, Inc. Assets for the quarter ending September 30, 2024 was $511M, a 64.2% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$511M	+$200M	+64.2%	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$532M	+$201M	+60.8%	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$554M	+$207M	+59.9%	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$340M	-$27.1M	-7.37%	Dec 31, 2023	10-Q	2024-11-07
Q3 2023	$311M	-$65.8M	-17.4%	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$331M	+$73.2M	+28.4%	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$346M	+$73.7M	+27%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$367M	+$81.9M	+28.7%	Dec 31, 2022	10-K	2024-02-22
Q3 2022	$377M	+$82.7M	+28.1%	Sep 30, 2022	10-Q	2022-11-03
Q2 2022	$257M	-$46.1M	-15.2%	Jun 30, 2022	10-Q	2022-08-04
Q1 2022	$273M	-$38.5M	-12.4%	Mar 31, 2022	10-Q	2022-05-11
Q4 2021	$285M	+$154M	+118%	Dec 31, 2021	10-K	2023-02-23
Q3 2021	$294M			Sep 30, 2021	10-Q	2021-11-10
Q2 2021	$303M			Jun 30, 2021	10-Q	2021-08-09
Q1 2021	$311M			Mar 31, 2021	10-Q	2021-05-13
Q4 2020	$131M			Dec 31, 2020	10-K	2022-02-24

* An asterisk sign (*) next to the value indicates that the value is likely invalid.